CIP2A and SET are endogenous inhibitors of the phosphatase 2A (PP2A), a tumor suppressor protein that is recurrently inactivated in acute and chronic myeloid leukemias [7]. This evidence concerns the gene CIP2A and chronic myelogenous leukemia, BCR-ABL1 positive.